Abstract
Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100% event-free survival.
Original language | English (US) |
---|---|
Pages (from-to) | 2246-2248 |
Number of pages | 3 |
Journal | Pediatric Blood and Cancer |
Volume | 63 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1 2016 |
Externally published | Yes |
Keywords
- case series
- sarcoma
- undifferentiated embryonal sarcoma of the liver
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology